Content & Events

What's New At Scorpius

BIO International Convention 2024

San Diego, CA, USA

Meet with Scorpius at BIO 2024 in San Diego.

BOOK A MEETING

NightHawk Biosciences Completes Name Change to Scorpius Holdings

NightHawk Biosciences announced its name change to Scorpius Holdings, Inc., to better reflect the company’s successful shift into a pure-play, large molecule biomanufacturing CDMO.

February 6, 2024

Scorpius' Ania Szymanska Featured in Pharmaceutical Technology’s February 2024 E-book

Scorpius BioManufacturing's Site Head of Quality, Ania Szymanska shares her expertise on how to evaluate a CDMO’s commitment to quality in Pharmaceutical Technology’s February 2024 E-book.

Scorpius Corporate Video

Learn more about our boutique biologics facility in San Antonio, TX

Non-Dilutive Funding—An Excellent Option for Biotech Startups

Sources of non-dilutive funding to advance early-stage biotech programs through clinical trial manufacturing, from biologics CDMO Scorpius BioManufacturing

BioProcessing Summit 2024

August 19-22, 2024

Boston, MA, USA

Meet with Scorpius at the BioProcessing Summit in Boston.

BOOK A MEETING

hubXchange San Francisco 2024

September 23-24, 2024

San Francisco, CA, USA

Meet with Scorpius at the Advanced Therapies & Antibody Therapeutics Xchange in San Francisco.

BOOK A MEETING

October 8-10, 2024

Meet with Scorpius at CPHI to discuss how we can meet your biomanufacturing and bioanalytical needs.

BOOK A MEETING

Bench To The Clinic: Biomanufacturing 101 for University Researchers

Discover how Scorpius BioManufacturing can assist University researchers in navigating translational biomanufacturing.

How to Create a Successful Business and Technical Relationship with a CDMO

Scorpius BioManufacturing shares customer input on what makes for a successful business and technical relationship between sponsors and biologics CDMO.

February 6, 2024

Scorpius BioManufacturing Announces Joe Payne as President and Chief Operating Officer

Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), promoted Joe Payne to President and COO.

February 1, 2024

Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)

Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)

December 8, 2023

How to Select the Right Biologics CDMO Partner

The article discusses essential & strategic considerations throughout the biologics CDMO selection process, including weighing options to make the best decisions.

December 1, 2023

Evaluating Biologics CDMOs: Tips for Crafting an RFP

Suggestions for designing an effective RFP for a biologics CDMO selection process, including how to approach RFP design & the information it should gather.

November 14, 2023

From frustration to innovation: a CDMO’s mission to empower emerging biotechs

Capacity, capacity, capacity. This seems to be all the industry talks about. A global pandemic magnified the need for more biologics manufacturing capacity. Capacity, however, isn’t the whole story.

October 20, 2023

5 New Questions to Ask Before Signing with a Biologics CDMO

This article discusses the current value biologics CDMOs bring to their innovator customers and new questions for selecting a CDMO partner.

October 17, 2023

Top 6 Questions to Ask When Evaluating a Biologics CDMO

When selecting a biologics CDMO partner, an innovator must ask the right questions to make the best decision. This article shares six top considerations.

September 12, 2023

3 Trends Innovative Biologics CDMOs Are Embracing

Deep Dive: Top 3 Biologics Trends Shaping the Future with Scorpius.

Does Your Biologics CDMO Truly Have a Culture of Quality?

Joe Payne, Scorpius' President & COO, shares what 20+ years in pharma has taught him about creating a culture of quality.

Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM₁₉₇

Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), for the production of an E.coli-expressed CRM₁₉₇ conjugate ...

Scorpius Highlighted In Drug Development & Delivery's Annual Report

Scorpius highlighted in Drug Development & Delivery's annual CDMO report

Scorpius Expands Leadership Team With New VP, Manufacturing Operations

Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), expanded its leadership to include Matthew R. LeClair.

Emerging Horizons: The Evolving Biologics Trends

Unveiling the Future: Biologics Development & Key Industry Shifts with Scorpius.

Biologics Outsourcing: Decision Drivers and Key Considerations

A recent survey of 100 decision makers at innovative biologics companies revealed 57% of respondents believe their companies’ outsourcing activities will increase over the next two years, while a furt...

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

By providing end-to-end services — including secure supply chains — CRO/CDMOs, like Scorpius BioManufacturing can help biologics developers meet accelerated timelines and establish a real competitive ...

January 31, 2023

The Bioanalytical Development Journey

Biopharma companies outsource pharmaceutical development and manufacturing from discovery, bioanalytical testing, qualification to validation.

Evaluating Single-Use Technologies for Biomanufacturing

Single-use technologies (SUTs) are ideal for multiproduct facilities producing smaller volumes of materials.

November 22, 2021

ABC: Analytics for Biomanufacturing and Clinical Trials of Biomanufactured Products

Samir Lakhashe, Director, Bioanalysis, discusses assay categorization, the company's growing toolbox, predictions for the future, and what scientists who want to join the growing team should know, wit...

October 15, 2021